Abstract
Background and ImportanceThe dual antiplatelet therapy(DAPT) consisting of acetylsalicylic acid plus one P2Y12 platelet receptor inhibitor represents the first line to treat patients with diagnosis of acute coronary syndrome (ACS).Aim...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
